Want to join the conversation?
$BAX's sales within the U.S. for 4Q15 rose 1% to $1.1Bil, while international sales totaled $1.5Bil, representing a 2% increase on a constant currency basis, and 12% decline on a reported basis. Adjusting for impact of FX and generic market entrant in the U.S. for its oncology injectable, cyclophosphamide, $BAX's global sales rose 4%.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.